Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses

Gastroenterology

Volumn 151, Issue 6, 2016, Pages 1251-1253

  Wang, Wenshi ^a   Hakim, Mohamad S ^a   Nair, Vidya P ^b   de Ruiter, Petra E ^a   Huang, Fen ^c   Sprengers, Dave ^a   Van Der Laan, Luc J W ^a   Peppelenbosch, Maikel P ^a   Surjit, Milan ^b   Pan, Qiuwei ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE   (India)

^c KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; SOFOSBUVIR; VIRUS RNA; ANTIVIRUS AGENT; VIRUS DNA;

ANTIVIRAL ACTIVITY; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG POTENCY; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; LETTER; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; CHRONIC HEPATITIS C; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HEPACIVIRUS; LIVER CELL; TUMOR CELL LINE; VIROLOGY;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; HEK293 CELLS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATITIS E; HEPATITIS E VIRUS; HEPATOCYTES; HUMANS; RNA, VIRAL; SOFOSBUVIR; VIRUS REPLICATION;

EID: 84997112245     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.09.061     Document Type: Letter

References (8)

1. 1 Dao Thi, V.L., et al. Gastroenterology 150 (2016), 82–85.
2. 2 Wang, W., et al. Gastroenterology, 150, 2016, 1690.
3. 3 Frese, M., et al. Hepatology 35 (2002), 694–703.
4. 4 Wakita, T., Pietschmann, T., et al. Nat Med 11 (2005), 791–796.
5. 5 Nair, V.P., et al. PLoS Pathog, 12, 2016, e1005521.
6. 6 Kamar, N., et al. Lancet 379 (2012), 2477–2488.
7. 7 Wu, K.T., et al. J Med Virol 81 (2009), 1734–1742.
8. 8 Summers, B.B., et al. J Pharm Pharmacol 66 (2014), 1653–1666.